Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06094946Not Yet Recruiting

Parturient Satisfaction With Epidural Analgesia by PCEA or Manual Boluses

Role: lead

NCT04645823Phase 4Completed

Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor

Role: lead

NCT05396430Not ApplicableUnknown

Duration of Urinary Catheter Treatment After Cesarean Delivery Under Spinal Anesthesia

Role: lead

NCT05396417Unknown

How Well do the Current Cesarean Deliveries Adhere to the Published ERAS Guidelines?

Role: lead

NCT05396378Unknown

Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose

Role: lead

All 5 trials loaded